EXANE DERIVATIVES: KNX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KNX, newest first. How the timeline and the estimate are built.
EXANE DERIVATIVES held 0 KNX shares at 2022-03-31 per its 13F-HR filed 2022-04-22.
the latest 13F is the newest step
- period ended2022-03-3113F 0 sharesChange vs previous 13F -58 shares
13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2021-12-3113F 58 sharesChange vs previous 13F +58 shares
<0.01% of the 13F portfolio, value $3,535.
13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-09-3013F 0 sharesChange vs previous 13F -49 shares
13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2021-06-3013F 49 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $2,446.
13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-03-3113F 49 sharesChange vs previous 13F +49 shares
<0.01% of the 13F portfolio, value $2,357.
13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2020-12-3113F 0 sharesChange vs previous 13F -206 shares
13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2020-09-3013F/A 206 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $8,384.
13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).